NCT05952947 2024-02-02HRYZ-T101 Injection for HPV18 Positive Solid TumorHRYZ Biotech Co.Phase 1 Recruiting32 enrolled
NCT05069935 2023-09-21FT538 in Combination With Monoclonal Antibodies in Advanced Solid TumorsFate TherapeuticsPhase 1 Terminated16 enrolled